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T cell responses to low-affinity T cell receptor (TCR)
ligands occur in the context of infection, tumors,
and autoimmunity despite diminished TCR signal
strength. The processes that enable such responses
remain unclear. We show that distinct mechanisms
drive effector/memory development in high- and
low-affinity T cells. Low-affinity cells preferentially
differentiate into memory precursors of a central
memory phenotype that are interleukin (IL)-12Rlo,
IL-7Rhi, and Eomeshi. Strikingly, in contrast to naive
cells, low-affinity memory cells were impaired in the
response to low- but not high-affinity ligands, indi-
cating that low-affinity cells are programmed to
generate diverse immune responses while avoiding
autoreactivity. Affinity and antigen dose directly
correlated with IL-12R signal input and T-bet but
not with Eomes expression because low- affinity
signals were more potent inducers of Eomes at a
high antigen dose. Our studies explain how weak
antigenic signals induce complete primary immune
responses and provide a framework for therapeutic
intervention.INTRODUCTION
CD8 T cell memory contributes to the health of an individual by
providing protection against re-exposure to intracellular patho-
gens and tumors. High-affinity interactions between the T cell
receptor (TCR) and peptide-MHC ligands lead to acquisition of
effector function and generation of long-term memory (Corse
et al., 2011; Gourley et al., 2004). Interactions with low-affinity
self-peptide MHC molecules are necessary for the survival of
naive peripheral T cells (Jameson, 2005; Sprent et al., 2008).
Strikingly, these low-affinity interactions are sufficient for the
acquisition of effector function and memory differentiation
(Zehn et al., 2009). This challenges the notion that central toler-
ance leads to complete nonresponsiveness to self and suggests554 Cell Reports 4, 554–565, August 15, 2013 ª2013 The Authorsan important role for low-affinity T cell interactions in the periph-
eral lymphoid compartment.
The biological significance of generating low-affinity memory
T cells becomes evident when considering the following: first,
low-affinity T cells are significant contributors to the effector
response against autoantigens, tumors, and pathogens (Pardoll,
2002; Sabatino et al., 2011). Second, low-affinity T cells can
participate in the maintenance of a diverse memory repertoire
(Intlekofer et al., 2006). This may be especially relevant with
age considering the drop in thymic output upon puberty (Ahmed
et al., 2009; den Braber et al., 2012; Hale et al., 2006; Naylor
et al., 2005). Additionally, this may be advantageous to control
microbes that mutate T cell epitopes in an effort to evade the
immune response (van Gisbergen et al., 2011). Therefore, under-
standing a T cells’ ability to respond to low-affinity ligands is a
critical aspect of T cell immunity.
How low-affinity TCR-peptide-MHC interactions lead to T cell
effector andmemory differentiation is not known. Studies of TCR
signaling in response to low-affinity ligands have demonstrated
that changes in potency are quantitatively and qualitatively
unique and cannot be explained by simple antigen dose effects.
Seminal studies with altered peptide ligands have shown that the
TCR has the ability to trigger specific signaling events that
support some functions but not others depending on the nature
of the TCR-peptide-MHC interaction (Daniels et al., 2006; Davis
et al., 1998; Jameson and Bevan, 1995; Jameson et al., 1993;
Koniaras et al., 1999; Madrenas et al., 1995; Sloan-Lancaster
et al., 1994a, 1994b). Therefore, low-affinity TCR interactions
do not necessarily imply an overall dampening of TCR signal
but rather may lead to qualitative changes in signal output that
are sufficient to support unique T cell responses. Additionally,
in the context of an immune response, TCR and proinflammatory
signals cooperate to regulate T cell differentiation (Mescher
et al., 2006). However, whether this is dependent on TCR affinity
is poorly defined.
The T-box transcription factors T-bet and Eomes are crucial
for effector and memory differentiation in T cell immune
responses (Intlekofer et al., 2005). Both are induced by high-
affinity TCR ligands and modulated by the proinflammatory
cytokine interleukin (IL)-12 (Takemoto et al., 2006). Studies
with T-bet and Eomes-deficient mice suggest that both can
act redundantly to induce effector functions. However, although
T-bet suppresses Eomes expression and promotes terminal
short-lived effector differentiation, Eomes supports self-renewal
of antigen-specificmemory cells, without affecting T-bet expres-
sion (Banerjee et al., 2010; Intlekofer et al., 2007). Thus, T-bet
and Eomes expression profiles may be useful to predict the effi-
ciency of generating a memory pool. Curiously, there is little
insight into how TCR affinity impacts T-bet and Eomes expres-
sion profiles for effector/memory differentiation.
Central and peripheral tolerance mechanisms regulate the
delicate balance between protective immunity and autoimmunity
during an immune response. Central tolerance is regulated by a
sharp border that defines the difference between positive and
negative selection (Daniels et al., 2006; Naeher et al., 2007).
This is an imperfect process, and there is considerable evidence
for self-reactive clones that escape negative selection and can
cause autoimmunity (Enouz et al., 2012; Hogquist et al., 2005;
Liston et al., 2005). These cells, then, are kept in check by periph-
eral tolerance mechanisms to avoid autoimmunity. Among these
mechanisms, transforming growth factor (TGF)-b signaling is
critically important to control low-affinity T cell responses (Gore-
lik and Flavell, 2002; O’Sullivan et al., 2011; Zhang and Bevan,
2012). Therefore, for low-affinity T cells to develop effector func-
tion and memory without causing autoimmunity, one could envi-
sion a scenario where the quantity and/or quality of TCR signals
regulate susceptibility to inflammation and tolerance, shaping
memory programming in a way that maximizes diversity of the
memory pool and limits induction of autoimmunity.
We tested this hypothesis with the OT-I TCR transgenic sys-
tem. We compared immune responses to the strongest negative
selecting peptide, N4 (agonist), and the strongest positive
selecting ligand, Q4H7 (pseudo-self), and studied how differ-
ences in TCR affinity influence T cell memory programming
and the susceptibility of T cells to inflammatory and regulatory
signals. We show that high- and low-affinity T cells are different
in their effector/memory programming. We provide mechanistic
data about how TCR affinity, IL-12, and TGF-b signals interplay
to modify this distinct program. We propose that quantity (anti-
gen dose) and quality of the signal triggered by the stimulating
TCR ligand not only determine the nature of the primary immune
response but also have a profound impact on programming the
sensitivity to low-affinity ligands during the secondary immune
response.
RESULTS
T Cells Responding to High- and Low-Affinity Ligands
Are Phenotypically Different
Numerous studies have led to the general conclusion that activa-
tion of a T cell is proportional to TCR ligand affinity (Gottschalk
et al., 2010). Contrary to this, low-affinity T cells significantly
contribute to the effector response against autoantigens and
pathogens by developing into effector and memory cells (Zehn
et al., 2009), which may pose a risk for autoimmunity. Thus, we
sought to understand how very-low-affinity TCR ligands (in the
range of positive selectors) are able to support these T cell fates.
For this, we compared the responses against the cognate anti-
gen for the OT-1 TCR, N4 (SIINFEKL), and the strongest positive
selecting ligand Q4H7 (SIIQFEHL). Q4H7 selection potential wasdetermined by analysis of a large panel of N4 variants in fetal
thymic organ culture. It was found to have the highest affinity
and potency and still induce positive selection of OT-1 T cells
(Daniels et al., 2006). We deliberately chose Q4H7 because it
would potentially present the highest risk for a positive selecting
ligand to induce dangerous autoreactivity. As expected, Listeria
monocytogenes (LM) expressing Q4H7 induced a much weaker
response than LM-N4. Both LM-N4 and Q4H7 T cell responses
gave rise to stable T cell memory pools. However, the ratio of
effector to memory in response to LM-N4 and LM-Q4H7 were
different (Figure 1A). As expected, 5%–10% of the cells present
at the peak of the LM-N4 response survived contraction and
established the memory pool (Williams and Bevan, 2007). Inter-
estingly, in LM-Q4H7 responses, an approximately 6-fold higher
ratio of T cells present at the peak ended up in the memory pool.
This suggests that although low-affinity effector cell numbers
were diminished, the percentage of low-affinity memory cells
generated was comparatively increased. Looking further, we
measured IL-7Ra expression as a surrogate marker for memory
precursors during the immune response. T cells responding to
LM-Q4H7 (low affinity) exhibited a substantially higher percent-
age of memory precursors than their LM-N4 (high affinity)
counterparts (Figure 1B, left) (King et al., 2012). Furthermore,
low-affinity responders expressed higher levels of IL-7Ra than
naive or high-affinity responders at the peak of the response (Fig-
ure 1B, right), supporting the idea that antigen controls IL-7Ra
levels (Hammerbeck and Mescher, 2008). IL-7Rhi cells respond-
ing to LM-Q4H7 exhibited an activated phenotype (CD44hi,
Granzyme Bhi, etc), discarding the possibility they were unstimu-
lated naive T cells (data not shown). The percentage of CD62Lhi
cells was significantly higher in response to LM-Q4H7 than to
LM-N4, suggesting a correlation between TCR affinity and cen-
tral memory phenotype (Figure 1C). Yet, the number of cells with
IL-7Rhi and CD62Lhi phenotypes was significantly lower in low-
affinity T cells (Figure S1). Low-affinity IL-7Rhi CD62Lhi T cells
were present at similar frequencies in spleen, lymph nodes,
and bone marrow, indicating they do not preferentially accumu-
late in one of these organs. Interestingly, a higher frequency of
low-affinity cells remained CD27hi (Figure 1D), correlating with
the idea that its expression is required for low-affinity T cells to
develop into memory (van Gisbergen et al., 2011). Collectively,
these data show that T cells responding to high- and low-affinity
TCR ligands are phenotypically different during the course of
listeria infection and low-affinity T cells primarily develop into
memory precursors with a central memory phenotype.
Low-Affinity TCR Ligands Trigger a Distinct Effector/
Memory Program
These results suggest that low-affinity T cells preferentially
differentiate into memory at the expense of effectors or, alterna-
tively, they are less efficiently recruited into the effector pool
whereas memory development remains intact (or both). To
distinguish between these possibilities, we investigated how
low-affinity TCR ligands support effector and memory program-
ming by examining the expression of T-bet and Eomes (Kallies,
2008; Rutishauser and Kaech, 2010). Naive OT-1 T cells were
stimulated with 20 nM of N4 or Q4H7 peptide pulsed antigen-
presenting cells (APCs) and T-bet and Eomes expression wasCell Reports 4, 554–565, August 15, 2013 ª2013 The Authors 555
Figure 1. Low-Affinity Cells Preferentially
Differentiate into Central Memory Pre-
cursors
(A–D) OT-I T cells (1 3 103) were transferred into
congenic B6 hosts and challenged with 1 3 103
colony-forming units (cfu) LM-N4 or LM-Q4H7.
(A) Frequency of cells during the immune response
to LM-N4 (left) or LM-Q4H7 (right) in blood. Ratio
shown as mean ± SD.
(B) Frequency of cells expressing IL-7Rhi in blood
(left). For all data points except day 35, p < 0.0001.
Bar graph represents expression of IL-7R (mean
fluorescence intensity, MFI) in IL-7Rhi and IL-7Rlo
populations in lymph nodes at day 6 (right). Geo-
metric MFIs were normalized to a naive control.
(C) Frequency of cells expressing CD62Lhi in
blood. For all data points except day 35, p <
0.0007. Day 35, p < 0.05.
(D) CD27, CD62L, and IL-7R expression in lymph
nodes, spleen, and bone marrow at day 6.
All graphs show mean ± SD and represent n R 3
independent experiments, with n R 3 mice per
experiment (*p < 0.05, **p < 0.005, ***p < 0.0005).
See also Figure S1.measured from days 1–4. We found that T cells responding
to Q4H7 expressed very low levels of T-bet (Figures 2A). In
contrast, low-affinity T cells expressed Eomes at much higher
levels than high-affinity cells (Figure 2B). This was not exclusive
to Q4H7, because we observed similar results with a lower affin-
ity pseudo-self TCR ligand (Q7) that we have previously
described in (Daniels et al., 2006) (Figure S2). Similar frequencies
of CD25+ and CD44+ cells were observed for Q4H7 (or Q7) and
N4 stimulation, ruling out that the differences in T-bet and Eomes
expression resulted from unstimulated naive OT-1 T cells (Fig-
ure S2). Thus, as TCR affinity decreased, T-bet expression
diminished, whereas the induction of the memory-associated
factor Eomes increased.
Because inflammation, andmore specifically IL-12, is required
for CD8 effector andmemory development (Xiao et al., 2009), we
also tested whether high levels of exogenous IL-12 differentially
affected the induction of T-bet and Eomes depending on TCR
affinity. IL-12 increased the expression of T-bet for T cells re-
sponding to low- and high-affinity TCR ligands. However, IL-12
did not enable Q4H7-stimulated cells to reach the T-bet levels
induced by N4 (Figures 2C and S2). More importantly, IL-12
did not alter Eomes expression for either ligand (Figures
2D and S2).556 Cell Reports 4, 554–565, August 15, 2013 ª2013 The AuthorsNext, we compared Eomes and T-bet
expression levels in T cells responding
to high- and low-affinity TCR ligands in
the context of infection. At the peak of
both immune responses, low-affinity cells
exhibited a 6-fold greater frequency of
cells expressing high levels of IL-7R and
Eomes than their high-affinity counter-
parts (Figure 2E). Furthermore, on a per-
cell basis, low-affinity T cells expressed
higher Eomes levels than high-affinitycells, confirming the in vitro results. We also observed a higher
frequency of low-affinity T cells expressing high levels of Bcl-6,
a transcription factor linked to memory development (Crotty
et al., 2010; Ichii et al., 2002). Interestingly, T-bet expression
in vivo was comparable between high- and low-affinity cells (Fig-
ure 2F). Overall, these data show that, in the context of infection,
low-affinity TCR ligands are able to induce T-bet levels compa-
rable to high-affinity ligands. More importantly, they are uniquely
capable of inducing very high levels of memory transcription
factors Eomes and Bcl-6. This suggests that low-affinity TCR
ligands induce a transcriptional program that favors memory
development.
TCR Signals Differentially Regulate Eomes and T-Bet
Expression
It seemed counterintuitive that weak TCR signals could induce
T-bet and Eomes equal to or better than strong cognate antigen.
Because antigen dose and/or inflammation shape a T cell
response, we examined the ability of OT-1 T cells to induce
T-bet and Eomes depending on antigen dose, in the absence
or presence of excess exogenous IL-12. T-bet expression was
directly proportional to TCR ligand affinity and antigen dose.
Although N4 was generally better at the induction of T-bet, there
Figure 2. Induction of Eomes, T-Bet, and Bcl-6 Expression in Low-Affinity Cells
(A–D) Naive OT-I splenocytes were stimulated with 20 nM N4 or Q4H7 peptide-pulsed APCs in the absence (A and B) or presence (C and D) of 2 ng/ml IL-12.
Expression of T-bet (A and C) and Eomes (B and D) were determined by flow cytometry on OT-1 T cells. Naive control (dashed line). Graphs showmean ± SD and
represent nR 5 independent experiments (*p < 0.05, **p < 0.005, ***p < 0.0005). OT-I naive T cells were transferred into congenic B6 hosts and challenged as in
Figure 1.
(E) Frequency of cells expressing IL-7Rahi Eomeshi at the peak of the LM-N4 and LM-Q4H7 immune responses (days 6–8) in blood. Dot plots are representative of
five independent experiments, nR 3 mice per condition.
(F) Eomes, T-bet, and Bcl-6 expression determined as in (A) on OT-1 donors at the peak of the LM-N4 and LM-Q4H7 immune responses (days 6–8). Isotype or
naive control, dashed line. Histograms and values are representative of three independent experiments, nR 3 mice per condition. Values showMFI (median) for
Eomes and T-bet and percentage of Bcl-6+ cells.
See also Figure S2.was no difference in T-bet expression between high- and low-
affinity ligands at the highest antigen doses (Figure 3A). On the
other hand, there was not a direct correlation between antigen
dose and TCR affinity for Eomes expression. At low antigen
doses (%1010M), Q4H7 induced lower levels of Eomes than
the high-affinity ligand N4. For N4, increase in antigen dose led
to more Eomes expression; however, at the highest doses
(R109 M), Eomes expression was repressed. Strikingly, at
these highest doses (R109 M), Q4H7 induced much higher
Eomes expression than N4. Importantly, high-affinity ligands
were unable to reach these levels of Eomes expression at
extremely low antigen doses (Figure 3B). This cannot beexplained by simple differences in TCR occupancy as it only
takes 5-fold higher concentration of low-affinity ligands to reach
the same level of occupancy of their high-affinity counterparts
(Daniels et al., 2006). Taken together, these data suggest that
the quality of the TCR signal has a greater affect on Eomes
expression than the quantity.
Next, we evaluated the effect of IL-12 on the pattern of T-bet
and Eomes expression. T-bet expression was increased in a
linear fashion across all doses for both TCR ligands with no
change in sensitivity. Furthermore, similar to results in the
absence of exogenous IL-12, low-affinity ligands only reached
T-bet levels comparable to the high-affinity ligands at the highestCell Reports 4, 554–565, August 15, 2013 ª2013 The Authors 557
Figure 3. TCR Signal Strength Regulates
T-Bet and Eomes in Distinct Ways
(A–D) Naive OT-I splenocyteswere stimulated with
APCs pulsed with varying concentrations of N4 or
Q4H7 peptides in the absence (A and B) or pres-
ence (C and D) of 2 ng/ml IL-12. Expression of
T-bet (A and C) and Eomes (B and D) was deter-
mined by flow cytometry as in Figure 2.
Graphs show mean ± SEM and are representative
of nR 4 independent experiments. *p < 0.05, **p <
0.005, ***p < 0.0005. See also Figure S3.antigen doses (Figure 3C). In contrast, we observed two unique
patterns of Eomes expression in the presence of exogenous
IL-12. At the lowest antigen doses, IL-12 decreased Eomes
expression for N4, whereas it increased Eomes levels for the
low-affinity ligand Q4H7. At high antigen doses, IL-12 did not
have any significant effect on Eomes expression for either ligand.
Yet, Eomes levels were much higher for low- than high-affinity
ligands (Figure 3D). Importantly, we found similar results with
other high- (negative selectors) and low-affinity (positive selec-
tors) ligands, indicating that these results are not restricted to
N4 and Q4H7 peptides (Figure S3). Of note, even at very low an-
tigen doses (2 3 1010M), low- and high-affinity cells were simi-
larly activated (Figure S3). Yet, Eomes and T-bet expression
were significantly different between high- and low-affinity cells,
reinforcing the idea that both TCR affinity and antigen dose regu-
late Eomes and T-bet expression in distinct ways. Additionally,
these results predict that the T-bet and Eomes expression profile
observed in low-affinity cells in vivo (Figure 2) may correspond to
T cells that have encountered high levels of low-affinity antigens.
TCR Signals Regulate the Susceptibility to IL-12
Given the effect of IL-12 on T-bet and Eomes was dependent on
TCR affinity and antigen dose, we hypothesized that TCR signals
regulate the ability of T cells to receive IL-12 signals. To test this,
we evaluated whether TCR affinity and antigen dose could regu-
late the expression of IL-12R. Naive OT-1 T cells were stimulated
with 20 nM N4 or Q4H7 peptide-pulsed APCs in the presence or
absence of exogenous IL-12. In the absence of exogenous IL-12,
N4 stimulation upregulated IL-12R expression by day 3. In
contrast, IL-12R expression was not induced upon stimulation
with the low-affinity ligand Q4H7 (Figure 4A). The addition of
exogenous IL-12 increased the expression of IL-12R for both558 Cell Reports 4, 554–565, August 15, 2013 ª2013 The AuthorsTCR ligands over naive levels by day 2
(Figure 4B). Yet, IL-12R expression
induced by the low-affinity ligand Q4H7
did not reach the levels induced by the
high-affinity TCR ligand N4. This was
also observed upon infection (Figure 4C).
Importantly, low IL-12R levels led to low
STAT-4 phosphorylation upon IL-12 stim-
ulation of low-affinity T cells (Figure 4D).
Because antigen dose had a profound
effect on T-bet and Eomes expression
for low-affinity ligands (Figure 3), we
next tested whether this also applied toIL-12R expression. The low-affinity TCR ligand Q4H7 was only
able to induce levels of IL-12R comparable to the high-affinity
ligand N4 at the highest antigen doses in both the presence
and absence of exogenous IL-12 (Figures 4E and 4F). Collec-
tively, these data clearly show that TCR signal strength (affinity
and antigen dose) regulates the ability of T cells to respond to
IL-12. Because IL-12 regulates T-bet andEomes expression, this
suggests that TCR signals regulate the input of IL-12 signals to
instruct effector/memory programming, and thereby, T cell fate.
TCR Signals Regulate the Susceptibility to TGF-b
Signals
TGF-b receptor signals negatively regulate the response of
T cells against low-affinity TCR ligands (Johnson and Jameson,
2012; Zhang and Bevan, 2012). Thus, we tested whether the
susceptibility to TGF-b signals was dependent on TCR signal
strength by measuring TGF-bRII expression in experiments
analogous to Figure 4. Interestingly, the low-affinity TCR ligand
Q4H7 only induced the downregulation of TGF-bRII to the levels
of the high-affinity TCR ligand N4 at the two highest antigen
doses (Figure 5A). Furthermore, the difference in TGF-bRII
expression between high- and low-affinity cells resulted in differ-
ences in TGF-bR signaling, as measured by phosphorylation of
SMAD2/3 (Figure 5B). These data strongly suggest that TCR
signal strength also dictates the susceptibility of T cells to
TGF-b regulation.
Low-Affinity Memory T Cells Are Impaired in Their
Effector Function in Response to Low-Affinity TCR
Ligands
The previous findings indicate that OT-1 T cells responding to
low-affinity TCR ligands in the presence of inflammation fully
Figure 4. TCR Affinity Regulates IL-12R
Expression and Signaling
(A and B) Naive OT-I splenocytes were stimulated
with 20 nM N4 or Q4H7 peptide-pulsed APCs in
the absence (A) or presence (B) of 2 ng/ml IL-12.
Expression of IL-12Rb2 (A and B) was determined
by flow cytometry. Naive control (dashed line).
(C) IL-12Rb1 expression on donor OT-1 cells
challenged as in Figure 1 at day 5 of the immune
response, in blood. Representative of n = 4.
(D) Phosphorylation of STAT-4 was determined on
high- and low-affinity cells upon 30 min of 2 ng/ml
IL-12 stimulation. Isotype control (dashed line).
Histograms representative of two independent
experiments.
(E and F) Naive OT-1 splenocytes were stimu-
lated as in Figure 3 and IL-12Rb1 expression was
determined as in (A). X denotes IL-12Rb1 expres-
sion in naive T cells.
All graphs show mean ± SEM and are represen-
tative of n R 4 independent experiments (*p <
0.05, **p < 0.005, ***p < 0.0005).support effector and memory programs. This could explain why,
in vivo, naive T cells responding to low-affinity ligands are able to
differentiate into effector and memory T cells (Zehn et al., 2009).
However, memory T cells are expected to be higher in frequency
and more sensitive to antigen than naive T cells (Williams and
Bevan, 2007). Thus, we wondered whether low-affinity memory
T cells would be more reactive to very-low-affinity antigens
(pseudo-self) and, hence, a higher risk for autoimmunity. For
this, we compared the response of naive T cells and memory
OT-1 T cells generated against LM-Q4H7 (low-affinity memory).
Low-affinity memory cells (CD44hi, IL-7Rhi) were isolated from
recipientmice. Then, equal numbers of naiveor low-affinitymem-
ory cells were transferred into naive congenic hosts and their
responses were compared upon infection with either LM-Q4H7
(low-affinity ligand) or LM-N4 (high-affinity ligand). As a control,
high-affinity OT-1 memory cells (generated in response to
LM-N4) were also rechallenged with high- or low-affinity ligands.
In response to LM-N4, low-affinity memory cells expanded simi-
larly to high-affinity memory cells (Figure 6A). Similar results were
observed in competition experiments where equal numbers of
high- and low-affinity memory cells were transferred into the
same congenic recipient followed by challenge with LM-N4 (Fig-
ure 6B). For memory effector function, we observed that low-af-
finity memory cells expressed Granzyme B and interferon (IFN)-g
at levels comparable to their high-affinity counterparts. However,Cell Reports 4, 554–565the percentage of low-affinity memory
cells able to perform these effector func-
tions was slightly but significantly lower
(Figures 6C and 6D). This suggests that
low-affinity memory T cells provide pro-
tection against high-affinity antigens,
although not to the same extent as high-
affinity memory T cells.
Next, we evaluated the response of
low-affinity memory T cells to low-affinity
ligands (LM-Q4H7 and LM-Q7). Low-affinity memory cell re-expansion in response to LM-Q4H7 or
-Q7 was substantially better than naive T cells and similar to
the re-expansion of high-affinity memory cells (Figure 7A; data
not shown). Strikingly, we found that low-affinity memory
T cells were impaired in the expression of Granzyme B, IFN-g,
T-bet, and Eomes (Figures 7B and 7C; data not shown). These
results are in marked contrast to the response of naive T cells
against LM-Q4H7, which is characterized by the expression of
Granzyme B and IFN-g at levels comparable to their high-affinity
counterparts (Figures 7B, 7C, and S4) (Zehn et al., 2009). These
data suggest, unexpectedly, that low-affinity memory T cells are
less efficient effectors than naive T cells in response to low-
affinity ligands. For high-affinity memory cells responding to
low-affinity ligands, expression of IFN-gwas also lower, whereas
Granzyme B was similar to naive cells (Figure S4). Collectively,
these results suggest that although both high- and low-affinity
memory T cells undergo normal secondary expansion, they are
impaired in their effector function against ligands in the range
of positive selectors. However, they remain reactive (although
not equally) to high-affinity ligands.
DISCUSSION
In the context of infection, low-affinity cells are able to acquire
effector function and develop into memory. However, the, August 15, 2013 ª2013 The Authors 559
Figure 5. TCR Affinity Regulates TGF-bRII Expression and Signaling
(A) Naive OT-I splenocytes were stimulated as in Figure 3, in the presence of
2 ng/ml IL-12 for 3 days. Expression of TGF-bRII was determined by flow
cytometry. Graph shows percentage of downregulation relative to naive T cells
(mean ± SEM, n = 5 independent experiments) (*p < 0.05, **p < 0.005, ***p <
0.0005).
(B) Naive OT-I splenocytes were stimulated with 0.2 nM N4 or Q4H7 peptide-
pulsed APCs for 3 days and stimulated with 5 ng/ml TGF-b for 30 min.
Phosphorylation of SMAD2/3 was determined by flow cytometry. Isotype
control (dashed line). Histograms representative of n = 2 independent
experiments.mechanisms that enable such responseswere unclear.We show
that low- and high-affinity T cells are unexpectedly different
in their effector/memory differentiation. Low-affinity cells ex-
pressed higher levels of Eomes and lower to equal levels of
T-bet compared to high-affinity cells. This results in low-affinity
cells primarily developing into memory precursors that rapidly
acquire a central memory phenotype. TCR signal strength
(affinity and antigen dose) distinctively regulated the expression
of these transcription factors, in part through the control of
IL-12R signals. Strikingly, and in contrast to naive T cells, both
high- and low-affinity memory T cells are partially desensitized
to low-affinity TCR ligands (in the range of positive selectors) in
secondary responses.
Most of our knowledge about T cell memory is based on data
generated in response to high-affinity ligands. From these
studies, a Goldilocks model of antigenic signal strength was pro-
posed, where ‘‘too little’’stimulation would lead to poor memory
development and ‘‘too much’’ would lead to CD8 memory
exhaustion (Gourley et al., 2004). This model, however, cannot
explain how, in lymphopenic conditions, naive T cells develop
into functional memory in response to self peptide (low affinity)
and low inflammatory signals. Furthermore, it cannot explain560 Cell Reports 4, 554–565, August 15, 2013 ª2013 The Authorshow, during infection, low-affinity TCR ligands can generate
memory T cells (Zehn et al., 2009). The data presented here
show that, transcriptionally, very-low-affinity TCR ligands have
the full potential to support effector function and develop into
memory (Cordaro et al., 2002; Turner et al., 2008; Zehn et al.,
2009). More importantly, low-affinity TCR ligands favor memory
by uniquely inducing high levels of Eomes and Bcl-6. How very
weak TCR signals are inherently better at inducing Eomes is
unclear. It may be related to a poor induction of T-bet. In fact,
in T-bet-deficient animals, IL-7R expression is higher, the num-
ber of memory precursors is increased, Eomes expression levels
are higher and central memory differentiation is enhanced upon
infection (Intlekofer et al., 2007). Consistent with this, low-affinity
T cells express higher levels of IL-7R, exhibit a higher frequency
of memory precursors that persist throughout an immune
response, and generate a higher percentage of cells with a cen-
tral memory phenotype (CD44hi, CD62Lhi) than high-affinity cells.
Low-affinity T cells are also poor inducers of T-bet in vitro and
require high doses of the low-affinity ligand to reach maximum
T-bet levels. Although we did not observe low expression of
T-bet in low-affinity cells in vivo, it may be that this is a sequential
process and a T-bet deficiency manifested earlier leads to a later
overexpression of Eomes. Alternatively, IL-12-independent sig-
nals, such as IL-7 or CD27, may play a role in T-bet or Eomes
induction, respectively (Dong et al., 2012; Li et al., 2011).
Curiously, we have made similar observations in polyclonal
responses where B6 mice were challenged with LM-OVA.
T cells that exhibited low binding to Kb-OVA tetramer had an
activated phenotype were higher for Eomes but equal for T-bet
expression. However, we cannot discard the fact that these
T cells might have also crossreacted with a Listeria epitope.
Proinflammatory signals have a profound impact on T cell
differentiation (Agarwal et al., 2009; Li et al., 2006; Zhang and
Bevan, 2012). Thus, high levels of inflammation are required to
drive effector function, but they also favor terminal effector dif-
ferentiation (Harty and Badovinac, 2008; Joshi et al., 2007;
Mescher et al., 2006; Pipkin et al., 2010). This is thought to be
in part because IL-12 enhances T-bet expression, which, in
turn, can repress Eomes levels (Intlekofer et al., 2007; Takemoto
et al., 2006). Although this may be true for high-affinity ligands,
our data provide an important insight into how Eomes expres-
sion is differentially regulated depending on affinity, antigen
dose, and the level of IL-12R. We find that, contrary to what
has been described for high-affinity ligands (Rao et al., 2010),
high IL-12 does not repress Eomes for low-affinity ligands and,
actually, has the opposite effect at low antigen doses. Strikingly,
at high antigen doses, IL-12 does not repress Eomes for either
TCR ligand. This indicates that IL-12-dependent regulation of
Eomes depends on TCR signal strength. This may be in part
linked to the regulation of IL-12R signals by TCR signal strength,
because low-affinity TCR ligands are poor inducers of IL-12R.
Alternatively, it may be that Eomes expression is negatively regu-
lated by very strong TCR signals (independently of IL-12) and
low-affinity ligands, even at the highest antigen doses, are not
able to trigger the mechanisms that induce this repression.
Another possibility could be that low-affinity TCR ligands are
inherently better inducers of a specific signaling pathway that
drives Eomes expression. Notably, TCR affinity does not
Figure 6. Low-Affinity Memory T Cells Respond to High-Affinity Ligands
OT-I CD8+ T cells (23 105) were transferred into congenic B6 hosts and challenged with 13 104 cfu LM-N4 or LM-Q4H7, and N4-primed (high-affinity memory
[Hi Aff. Mem]) or Q4H7-primed (low-affinity memory [Lo Aff. Mem]) memory cells were isolated afterR30 days.
(A, C, and D) Hi Aff. Mem or Lo Aff. Mem cells (13 104) were transferred into naive hosts and rechallenged with 13 105 cfu LM-N4. Frequency and total number of
responding cells (A), Granzyme B (C), and IFN-g expression (D) were determined in Hi and Lo Aff. Mem cells at day 6 postinfection (p.i.). Average MFI and
percentage of positive cells for Granzyme B and IFN-g are indicated. Graphs show mean ± SD.
(B) 13 104 Hi Aff Mem (CD45.2+CD90.1+), Lo Aff. Mem (CD45.2+CD90.1) or a mixture of 13 104 Hi Aff. Mem and 13 104 Lo Aff. Mem cells were transferred into
naive hosts and rechallenged with 1 3 105 cfu LM-N4. Frequency of responding cells was determined in the blood 5 days p.i.
Dot plots, histograms, and graphs are representative of nR 2 experiments, with three to six mice each. *p < 0.05, **p < 0.005, ***p < 0.0005.regulate T-bet expression in the same way as Eomes. T-bet
levels increase proportionally to TCR affinity. The positive influ-
ence of IL-12 in T-bet expression equally applies to both high-
and low-affinity ligands. Collectively, these findings provide
evidence that TCR affinity can differentially regulate transcription
factors (T-bet and Eomes) that are associatedwith different T cell
fates. This also supports previous data indicating that the TCR
signaling requirements for effector function and memory devel-
opment are different (Smith-Garvin et al., 2010; Teixeiro et al.,
2009) and raises the intriguing idea that TCR signals could be
manipulated to direct a T cell toward a specific fate.
It has been reported that inflammation regulates TCR sen-
sitivity to antigen (Richer et al., 2013). Remarkably, our data
demonstrate that TCR signal strength also regulates the
response of a T cell to inflammatory signals. Hence, because
there is a mutual regulation and cooperation of both signals,
neither inflammation nor antigenic signals can be considered
alone to fully understand CD8 T cell differentiation.
For low-affinity T cells, negative regulation by TGF-b signals
has an important impact in their immune response (Johnsonand Jameson, 2012; Zhang and Bevan, 2012). We have
observed that low-affinity T cells are unable to downregulate
TGF-bRII (except at the highest antigen doses), even in the pres-
ence of IL-12. TGF-bR signals have been shown to regulate CD8
short-lived effector cell survival but do not affect memory cell
development (Sanjabi et al., 2009). This adds credence to the
idea that low-affinity TCR signals favor memory differentiation,
maybe at the expense of effector differentiation. The fact that
TCR signal strength regulates both IL-12R and TGF-bR signals
suggests that low-affinity T cells need to be tightly regulated
(low for IL-12R signals and high for TGF-bR signals) to limit overt
activation in the context of infection. Thismay explain in part why
low-affinity T cells are able to differentiate to a certain extent but
do not cause stable autoimmunity (King et al., 2012).
In the thymus, a sharp border of TCR affinity defines the
threshold between positive selection of tolerant T cells and
the deletion of autoreactive T cells (Daniels et al., 2006). In the
periphery, these positively selected T cells are expected to
react against their cognate antigen and remain tolerant to self.
Because of this, it is striking that weak TCR signals from positiveCell Reports 4, 554–565, August 15, 2013 ª2013 The Authors 561
Figure 7. Low-Affinity Memory T Cells Are
Impaired in Their Effector Function against
Low-Affinity Ligands (Pseudo-self)
(A–C) Lo Aff. memory cells were obtained as in
Figure 6. Lo Aff. Mem or naive OT-I cells (1 3 104)
were transferred into naive hosts and challenged
with 13 105 (memory) or 13 104 (naive) cfu LM-N4
or LM-Q4H7or LM-Q7. Frequency and total num-
ber of responding cells (A), expression of Gran-
zyme B (B), and IFN-g (C) were determined by flow
cytometry in naive or Lo Aff Mem cells at day 6 p.i.
Values shown in dot plots are averages. Histo-
grams and graphs show mean ± SD. Data are
representative of nR 2 experiments, with three to
six mice each. Significance shown (*p < 0.05, **p <
0.005, ***p < 0.0005) denotes comparison versus
naive OT-I challenged with LM-Q4H7. See also
Figure S4.selecting ligands (low affinity) can induce complete immune
responses (Zehn et al., 2009). Based on our data, we propose
that the purpose of these responses is to maintain the diversity
of thememory repertoire. This could be crucial to protect against
viral escape variants and heterologous infections in secondary
immune responses (van Gisbergen et al., 2011) or tumors.
Intriguingly, low-affinity memory cells re-expanded in response
to low-affinity challenge but in contrast to naive T cells respond-
ing to low-affinity ligands in the range of positive selectors, they
were impaired in their effector function (IFN-g and Granzyme B
expression). This may be explained in part by the fact that low-
affinity memory cells exhibit higher levels of TGF-bRII than their562 Cell Reports 4, 554–565, August 15, 2013 ª2013 The Authorshigh-affinity counterparts (O’Sullivan
et al., 2011). Alternatively, this could be
a consequence of their memory pro-
gramming during the primary immune
response. Interestingly, low-affinity mem-
ory cells were able to respond against
high-affinity TCR ligands but not to the
same extent as high-affinity memory
cells. This suggests that low- and high-
affinity memory cell responses are not
equal, an idea that is also inferred in
studies comparing true memory T cells
(generated against strong antigens) and
HP-memory T cells (generated against
self-antigens in lymphopenic conditions)
(Cheung et al., 2009; Jellison et al., 2012).
Others have shown that monoclonal
or polyclonal T cells with low functional
avidity can escape negative selection
and after, being primed and/or rechal-
lenged with TCR ligands that are at or
below the threshold of negative selection,
can cause autoimmunity to tissue ex-
pressing self-antigen at or above this
threshold (Enouz et al., 2012; von Herrath
et al., 1994; Zehn and Bevan, 2006).
Our data suggest that reactivity againstligands below the threshold of positive selection could exist if
certain biochemical criterion is met. Thus, low-affinity T cells
were able to integrate TCR and IL-12R signals to support an
effector program (high levels of T-bet and Eomes) similar to
high-affinity ligands only at the highest doses of antigen in
the presence of inflammation. Interestingly, low-affinity primed-
OT-1 memory T cells, which are, in principle, more reactive
than naive T cells, were impaired in their ability to express
effector molecules IFN-g and Granzyme B but not in their ability
to proliferate upon rechallenge with positive selecting ligands
Q4H7 and Q7. This suggests that T cells mount restricted sec-
ondary responses to ligands in the range of positive selectors.
Is it possible that restriction could be overcome and lead to auto-
immunity? Polyclonal T cells from RIP-OVA mice challenged or
rechallenged with a pathogen that expresses OVA caused auto-
immunity in 30% of the RIP-OVA mice (Enouz et al., 2012). Curi-
ously, also in the RIP-OVAmodel, King et al. showed that, only at
high doses of the very low-affinity ligand (Q4H7), autoimmunity
was transiently induced (King et al., 2012), again suggesting
there may be a specific tolerance mechanism to keep these
responses in check below the threshold of negative selection.
The differences between these two systems highlight the impor-
tance of understanding the mechanisms that underlie breaks in
self-tolerance and indicate that the equilibrium between reac-
tivity to foreign and self is more complex than originally thought.
In summary, we show that high- and low-affinity memory
T cells are differentially programmed. Despite the fact that low-
affinity T cells are recruited into the memory pool, they undergo
normal secondary expansion, yet they are impaired in their
effector response to positive selecting ligands. Hence, we pro-
pose that the sharp TCR affinity threshold that distinguishes pos-
itive and negative selection is relevant for memory responses.
This information has important implications for vaccine develop-
ment, tumor immunotherapies, and autoimmunity.
EXPERIMENTAL PROCEDURES
Mice and Reagents
C57BL/6, B6.SJL, and OT-I and OT-1.PL (Thy1.1+) TCR transgenic mice were
bred andmaintained according to the University of Missouri OAR, ACUC. Pep-
tides were purchased from New England Peptides and rmIL-12 from Pepro-
tech. IL-2 (X63-IL-2 hybridoma) was used at 50 U/ml. TGF-b was from R&D
Systems.
Bacteria
Listeria strains were generously provided by M. Bevan (University of
Washington). Listeria strains were grown to an OD600 of 0.5 and were grown
as described in Zehn et al. (2009).
Adoptive Transfer and Infections
Donor naive (1 3 103–1 3 104) or memory OT-1 T cells were purified from the
lymph nodes of OT-1 or host mice and transferred intravenously into congenic
mice. All infections were performed intravenously at least 1 day after adoptive
transfer of transgenic T cells.
Flow Cytometry and Antibodies
Anti-CD8a (53–6.7), CD90.1 (OX-7), IL-7Ra (A7R34), CD62L (MEL-14), Vb5
(MR9-4), IL-12Rb1 (114), IL-12Rb2 (HAM10B9), IFN-g (XMG1.2), and phos-
pho-STAT-4 from BD PharMingen. Anti-CD45.1 (A20), CD45.2 (I04), CD27
(LG.7F9), and Eomes (Dan11Mag) were from eBioscience. Anti-T-bet (4B10)
and Bcl-6 (Clone 7D1) were from Santa Cruz Biotechnology, and secondary
antibodies and Granzyme B (GB12) were from Invitrogen. Anti-phospho-
SMAD2/3 was fromCell Signaling Technology. Flow cytometry was performed
on a FACSCalibur flow cytometer (Becton Dickinson), and the data were
analyzed with FlowJo FACS Analysis Software (Tree Star). For determining
induction of Eomes and T-bet, geometric mean fluorescent intensity was
normalized to a naive control. For determining induction of IL-12Rb2 and
IL-12Rb1, geometric mean fluorescent intensity was normalized to an isotype
control.
Intracellular Staining
Splenocytes were washed in FACS buffer (1% FCS, 0.02% sodium azide in
PBS) and stained for CD8 and congenic markers (CD45.1 or CD45.2 or
CD90.2 or CD90.1) to identify donor cells. Cells were washed in FACS buffer
and then fixed and permeabilized using Cytofix/Cytoperm or Phosflow(Perm. Buffer III) kit according to the manufacturer’s instructions (BD Biosci-
ences). Next, cells were stained with specific antibodies. For restimulation
and determining cytokine production, splenocytes were incubated in 96-well
round-bottom plates with 1 ml/ml Golgistop (BD Biosciences) in the presence
of 250 nMOVA or Q4H7 or Q7 peptides for 4 hr at 37C. Data were analyzed by
flow cytometry.
Statistical Analysis
For statistical analysis, unless otherwise stated in figures, two-tail unpaired
Student’s t test was applied using Prism software (GraphPad). Significance
was set at p < 0.05. For T-bet and Eomes dose-response curves (Figure 3),
data were analyzed using the multiple t tests platform (Holmes method correc-
tion for multiple comparisons, alpha = 5.000%), utilizing Prism software
(GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.07.008.
ACKNOWLEDGMENTS
This work was supported by University of Missouri Life Sciences Fellowship
(K.M.K.) and grants from University of Missouri Mission Enhancement Fund
and University of Missouri Research Board Grant. We thank M. Bevan and
D. Zehn for providing Listeria m strains and H. Mullen, S. McKarns, and B.
Hahm for providing reagents.
Received: February 6, 2013
Revised: May 18, 2013
Accepted: July 8, 2013
Published: August 8, 2013
REFERENCES
Agarwal, P., Raghavan, A., Nandiwada, S.L., Curtsinger, J.M., Bohjanen, P.R.,
Mueller, D.L., and Mescher, M.F. (2009). Gene regulation and chromatin
remodeling by IL-12 and type I IFN in programming for CD8 T cell effector
function and memory. J. Immunol. 183, 1695–1704.
Ahmed, M., Lanzer, K.G., Yager, E.J., Adams, P.S., Johnson, L.L., and Black-
man, M.A. (2009). Clonal expansions and loss of receptor diversity in the naive
CD8 T cell repertoire of aged mice. J. Immunol. 182, 784–792.
Banerjee, A., Gordon, S.M., Intlekofer, A.M., Paley, M.A., Mooney, E.C., Linds-
ten, T., Wherry, E.J., and Reiner, S.L. (2010). Cutting edge: The transcription
factor eomesodermin enables CD8+ T cells to compete for the memory cell
niche. J. Immunol. 185, 4988–4992.
Cheung, K.P., Yang, E., and Goldrath, A.W. (2009). Memory-like CD8+ T cells
generated during homeostatic proliferation defer to antigen-experienced
memory cells. J. Immunol. 183, 3364–3372.
Cordaro, T.A., de Visser, K.E., Tirion, F.H., Schumacher, T.N.M., and Kruis-
beek, A.M. (2002). Can the low-avidity self-specific T cell repertoire be
exploited for tumor rejection? Immunology 168, 651–660.
Corse, E., Gottschalk, R.A., and Allison, J.P. (2011). Strength of TCR-
peptide/MHC interactions and in vivo T cell responses. Immunology 186,
5039–5045.
Crotty, S., Johnston, R.J., and Schoenberger, S.P. (2010). Effectors andmem-
ories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat. Immunol.
11, 114–120.
Daniels, M.A., Teixeiro, E., Gill, J., Hausmann, B., Roubaty, D., Holmberg, K.,
Werlen, G., Holla¨nder, G.A., Gascoigne, N.R.J., and Palmer, E. (2006). Thymic
selection threshold defined by compartmentalization of Ras/MAPK signalling.
Nature 444, 724–729.
Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden, B., and
Chien, Y. (1998). Ligand recognition by alpha beta T cell receptors. Annu.
Rev. Immunol. 16, 523–544.Cell Reports 4, 554–565, August 15, 2013 ª2013 The Authors 563
den Braber, I., Mugwagwa, T., Vrisekoop, N., Westera, L., Mo¨gling, R., de
Boer, A.B., Willems, N., Schrijver, E.H., Spierenburg, G., Gaiser, K., et al.
(2012). Maintenance of peripheral naive T cells is sustained by thymus output
in mice but not humans. Immunity 36, 288–297.
Dong, H., Franklin, N.A., Roberts, D.J., Yagita, H., Glennie, M.J., and Bullock,
T.N. (2012). CD27 stimulation promotes the frequency of IL-7 receptor-
expressing memory precursors and prevents IL-12-mediated loss of CD8(+)
T cell memory in the absence of CD4(+) T cell help. J. Immunol. 188, 3829–
3838.
Enouz, S., Carrie´, L., Merkler, D., Bevan, M.J., and Zehn, D. (2012). Autoreac-
tive T cells bypass negative selection and respond to self-antigen stimulation
during infection. J. Exp. Med. 209, 1769–1779.
Gorelik, L., and Flavell, R.A. (2002). Transforming growth factor-beta in T-cell
biology. Nat. Rev. Immunol. 2, 46–53.
Gottschalk, R.A., Corse, E., and Allison, J.P. (2010). TCR ligand density and
affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207,
1701–1711.
Gourley, T.S., Wherry, E.J., Masopust, D., and Ahmed, R. (2004). Generation
and maintenance of immunological memory. Semin. Immunol. 16, 323–333.
Hale, J.S., Boursalian, T.E., Turk, G.L., and Fink, P.J. (2006). Thymic output in
aged mice. Proc. Natl. Acad. Sci. USA 103, 8447–8452.
Hammerbeck, C.D., and Mescher, M.F. (2008). Antigen controls IL-7R alpha
expression levels on CD8 T cells during full activation or tolerance induction.
J. Immunol. 180, 2107–2116.
Harty, J.T., and Badovinac, V.P. (2008). Shaping and reshaping CD8+ T-cell
memory. Nat. Rev. Immunol. 8, 107–119.
Hogquist, K.A., Baldwin, T.A., and Jameson, S.C. (2005). Central tolerance:
learning self-control in the thymus. Nat. Rev. Immunol. 5, 772–782.
Ichii, H., Sakamoto, A., Hatano, M., Okada, S., Toyama, H., Taki, S., Arima, M.,
Kuroda, Y., and Tokuhisa, T. (2002). Role for Bcl-6 in the generation and main-
tenance of memory CD8+ T cells. Nat. Immunol. 3, 558–563.
Intlekofer, A.M., Takemoto, N., Wherry, E.J., Longworth, S.A., Northrup, J.T.,
Palanivel, V.R., Mullen, A.C., Gasink, C.R., Kaech, S.M., Miller, J.D., et al.
(2005). Effector and memory CD8+ T cell fate coupled by T-bet and eomeso-
dermin. Nat. Immunol. 6, 1236–1244.
Intlekofer, A.M., Wherry, E.J., and Reiner, S.L. (2006). Not-so-great expecta-
tions: re-assessing the essence of T-cell memory. Immunol. Rev. 211,
203–213.
Intlekofer, A.M., Takemoto, N., Kao, C., Banerjee, A., Schambach, F., North-
rop, J.K., Shen, H., Wherry, E.J., and Reiner, S.L. (2007). Requirement for
T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
J. Exp. Med. 204, 2015–2021.
Jameson, S.C. (2005). T cell homeostasis: keeping useful T cells alive and live
T cells useful. Semin. Immunol. 17, 231–237.
Jameson, S.C., and Bevan, M.J. (1995). T cell receptor antagonists and partial
agonists. Immunity 2, 1–11.
Jameson, S.C., Carbone, F.R., and Bevan, M.J. (1993). Clone-specific T cell
receptor antagonists of major histocompatibility complex class I-restricted
cytotoxic T cells. J. Exp. Med. 177, 1541–1550.
Jellison, E.R., Turner, M.J., Blair, D.A., Lingenheld, E.G., Zu, L., Puddington, L.,
and Lefranc¸ois, L. (2012). Distinct mechanisms mediate naive and memory
CD8 T-cell tolerance. Proc. Natl. Acad. Sci. USA 109, 21438–21443.
Johnson, L.D., and Jameson, S.C. (2012). TGF-b sensitivity restrains CD8+
T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15.
PLoS ONE 7, e42268.
Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L.,
and Kaech, S.M. (2007). Inflammation directs memory precursor and short-
lived effector CD8(+) T cell fates via the graded expression of T-bet transcrip-
tion factor. Immunity 27, 281–295.
Kallies, A. (2008). Distinct regulation of effector and memory T-cell differentia-
tion. Immunol. Cell Biol. 86, 325–332.564 Cell Reports 4, 554–565, August 15, 2013 ª2013 The AuthorsKing, C.G., Koehli, S., Hausmann, B., Schmaler, M., Zehn, D., and Palmer, E.
(2012). T cell affinity regulates asymmetric division, effector cell differentiation,
and tissue pathology. Immunity 37, 709–720.
Koniaras, C., Carbone, F.R., Heath, W.R., and Lew, A.M. (1999). Inhibition of
naı¨ve class I-restricted T cells by altered peptide ligands. Immunol. Cell Biol.
77, 318–323.
Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.-K.L., and Flavell, R.A. (2006).
Transforming growth factor-beta regulation of immune responses. Annu.
Rev. Immunol. 24, 99–146.
Li, Q., Rao, R.R., Araki, K., Pollizzi, K., Odunsi, K., Powell, J.D., and Shrikant,
P.A. (2011). A central role for mTOR kinase in homeostatic proliferation
induced CD8+ T cell memory and tumor immunity. Immunity 34, 541–553.
Liston, A., Lesage, S., Gray, D.H., Boyd, R.L., and Goodnow, C.C. (2005).
Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol.
Rev. 204, 87–101.
Madrenas, J., Wange, R.L., Wang, J.L., Isakov, N., Samelson, L.E., and Ger-
main, R.N. (1995). Zeta phosphorylation without ZAP-70 activation induced
by TCR antagonists or partial agonists. Science 267, 515–518.
Mescher, M.F., Curtsinger, J.M., Agarwal, P., Casey, K.A., Gerner, M., Ham-
merbeck, C.D., Popescu, F., and Xiao, Z. (2006). Signals required for program-
ming effector and memory development by CD8+ T cells. Immunol. Rev. 211,
81–92.
Naeher, D., Daniels, M.A., Hausmann, B., Guillaume, P., Luescher, I., and
Palmer, E. (2007). A constant affinity threshold for T cell tolerance. J. Exp.
Med. 204, 2553–2559.
Naylor, K., Li, G., Vallejo, A.N., Lee, W.W., Koetz, K., Bryl, E., Witkowski, J.,
Fulbright, J., Weyand, C.M., and Goronzy, J.J. (2005). The influence of age
on T cell generation and TCR diversity. J. Immunol. 174, 7446–7452.
O’Sullivan, J.A., Zloza, A., Kohlhapp, F.J., Moore, T.V., Lacek, A.T., Dulin,
N.O., and Guevara-Patin˜o, J.A. (2011). Priming with very low-affinity peptide
ligands gives rise to CD8(+) T-cell effectors with enhanced function but with
greater susceptibility to transforming growth factor (TGF)b-mediated suppres-
sion. Cancer Immunol. Immunother. 60, 1543–1551.
Pardoll, D. (2002). T cells take aim at cancer. Proc. Natl. Acad. Sci. USA 99,
15840–15842.
Pipkin, M.E., Sacks, J.A., Cruz-Guilloty, F., Lichtenheld, M.G., Bevan, M.J.,
and Rao, A. (2010). Interleukin-2 and inflammation induce distinct transcrip-
tional programs that promote the differentiation of effector cytolytic T cells.
Immunity 32, 79–90.
Rao, R.R., Li, Q., Odunsi, K., and Shrikant, P.A. (2010). The mTOR kinase
determines effector versus memory CD8+ T cell fate by regulating the expres-
sion of transcription factors T-bet and eomesodermin. Immunity 32, 67–78.
Richer, M.J., Nolz, J.C., and Harty, J.T. (2013). Pathogen-specific inflamma-
tory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell
receptor signaling. Immunity 38, 140–152.
Rutishauser, R.L., and Kaech, S.M. (2010). Generating diversity: transcrip-
tional regulation of effector and memory CD8 T-cell differentiation. Immunol.
Rev. 235, 219–233.
Sabatino, J.J., Jr., Huang, J., Zhu, C., and Evavold, B.D. (2011). High preva-
lence of low affinity peptide-MHC II tetramer-negative effectors during
polyclonal CD4+ T cell responses. J. Exp. Med. 208, 81–90.
Sanjabi, S., Mosaheb, M.M., and Flavell, R.A. (2009). Opposing effects of
TGF-beta and IL-15 cytokines control the number of short-lived effector
CD8+ T cells. Immunity 31, 131–144.
Sloan-Lancaster, J., Evavold, B.D., and Allen, P.M. (1994a). Th2 cell clonal
anergy as a consequence of partial activation. J. Exp. Med. 180, 1195–1205.
Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B., and Allen, P.M. (1994b).
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment
in APL-induced T cell anergy. Cell 79, 913–922.
Smith-Garvin, J.E., Burns, J.C., Gohil, M., Zou, T., Kim, J.S., Maltzman, J.S.,
Wherry, E.J., Koretzky, G.A., and Jordan, M.S. (2010). T-cell receptor signals
direct the composition and function of the memory CD8+ T-cell pool. Blood
116, 5548–5559.
Sprent, J., Cho, J.-H., Boyman, O., and Surh, C.D. (2008). T cell homeostasis.
Immunol. Cell Biol. 86, 312–319.
Takemoto, N., Intlekofer, A.M., Northrup, J.T., Wherry, E.J., and Reiner, S.L.
(2006). Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin
expression during pathogen-induced CD8+ T cell differentiation. J. Immunol.
177, 7515–7519.
Teixeiro, E., Daniels, M.A., Hamilton, S.E., Schrum, A.G., Bragado, R.,
Jameson, S.C., and Palmer, E. (2009). Different T cell receptor signals deter-
mine CD8+ memory versus effector development. Science 323, 502–505.
Turner, M.J., Jellison, E.R., Lingenheld, E.G., Puddington, L., and Lefranc¸ois,
L. (2008). Avidity maturation of memory CD8 T cells is limited by self-antigen
expression. J. Exp. Med. 205, 1859–1868.
van Gisbergen, K.P.J.M., Klarenbeek, P.L., Kragten, N.A.M., Unger, P.-P.A.,
Nieuwenhuis, M.B.B., Wensveen, F.M., ten Brinke, A., Tak, P.P., Eldering,
E., Nolte, M.A., and van Lier, R.A. (2011). The costimulatory molecule CD27
maintains clonally diverse CD8(+) T cell responses of low antigen affinity to
protect against viral variants. Immunity 35, 97–108.vonHerrath, M.G., Dockter, J., and Oldstone, M.B. (1994). How virus induces a
rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.
Immunity 1, 231–242.
Williams, M.A., and Bevan, M.J. (2007). Effector and memory CTL differentia-
tion. Annu. Rev. Immunol. 25, 171–192.
Xiao, Z., Casey, K.A., Jameson, S.C., Curtsinger, J.M., and Mescher, M.F.
(2009). Programming for CD8 T cell memory development requires IL-12 or
type I IFN. J. Immunol. 182, 2786–2794.
Zehn, D., and Bevan, M.J. (2006). T cells with low avidity for a tissue-restricted
antigen routinely evade central and peripheral tolerance and cause autoimmu-
nity. Immunity 25, 261–270.
Zehn, D., Lee, S.Y., and Bevan, M.J. (2009). Complete but curtailed T-cell
response to very low-affinity antigen. Nature 458, 211–214.
Zhang, N., and Bevan, M.J. (2012). TGF-b signaling to T cells inhibits autoim-
munity during lymphopenia-driven proliferation. Nat. Immunol. 13, 667–673.Cell Reports 4, 554–565, August 15, 2013 ª2013 The Authors 565
